Patents by Inventor R. Diebold

R. Diebold has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8293904
    Abstract: The present invention provides novel osmium-based electrochemical species for the detection of wide variety of analytes using immunological techniques. The present invention also provides diagnostic kits and test sensors supporting electrode structures that can be used with the osmium-based electrochemical species. The test sensor can be fabricated to support interdigitated arrays of electrodes that have been designed to provide amplification of the electrical signal amplification desired to analyze analytes that may be present at low concentrations.
    Type: Grant
    Filed: September 20, 2011
    Date of Patent: October 23, 2012
    Assignee: Roche Diagnostics Operations, Inc.
    Inventors: Eric R. Diebold, Mitali Ghoshal, David Z. Deng, Jane S. C. Tsai
  • Patent number: 8288544
    Abstract: The present invention provides novel osmium-based electrochemical species for the detection of wide variety of analytes using immunological techniques. The present invention also provides diagnostic kits and test sensors supporting electrode structures that can be used with the osmium-based electrochemical species. The test sensor can be fabricated to support interdigitated arrays of electrodes that have been designed to provide amplification of the electrical signal amplification desired to analyze analytes that may be present at low concentrations.
    Type: Grant
    Filed: July 1, 2004
    Date of Patent: October 16, 2012
    Assignee: Roche Diagnostics Operations, Inc.
    Inventors: Eric R. Diebold, Mitali Ghoshal, David Z. Deng, Jane S.C. Tsai
  • Patent number: 8287703
    Abstract: An electrochemical biosensor with electrode elements that possess smooth, high-quality edges. These smooth edges define gaps between electrodes, electrode traces and contact pads. Due to the remarkable edge smoothness achieved with the present invention, the gaps can be quite small, which provides marked advantages in terms of test accuracy, speed and the number of different functionalities that can be packed into a single biosensor. Further, the present invention provides a novel biosensor production method in which entire electrode patterns for the inventive biosensors can be formed all at one, in nanoseconds—without regard to the complexity of the electrode patterns or the amount of conductive material that must be ablated to form them.
    Type: Grant
    Filed: September 25, 2008
    Date of Patent: October 16, 2012
    Assignees: Roche Diagnostics Operations, Inc., Roche Operations Ltd.
    Inventors: Raghbir S. Bhullar, Eric R. Diebold, Brian S. Hill, Nigel Surridge, Paul Douglas Walling
  • Publication number: 20120205260
    Abstract: The present disclosure relates to various methods for measuring the amount of an analyte present in a biological fluid using an electrochemical testing process. Various embodiments are disclosed, including the use of AC test signals and the performance of tests having a Total Test Time within about 3.0 seconds or less, and/or having a clinically low Total System Error.
    Type: Application
    Filed: March 13, 2012
    Publication date: August 16, 2012
    Inventors: Eric R. Diebold, Terry A. Beaty, Harvey B. Buck, JR.
  • Publication number: 20120125788
    Abstract: The present invention provides novel osmium-based electrochemical species for the detection of wide variety of analytes using immunological techniques. The present invention also provides diagnostic kits and test sensors supporting electrode structures that can be used with the osmium-based electrochemical species. The test sensor can be fabricated to support interdigitated arrays of electrodes that have been designed to provide amplification of the electrical signal amplification desired to analyze analytes that may be present at low concentrations.
    Type: Application
    Filed: September 20, 2011
    Publication date: May 24, 2012
    Inventors: Eric R. DIEBOLD, Mitali GHOSHAL, David Z. DENG, Jane S.C. TSAI
  • Patent number: 8148164
    Abstract: The present disclosure relates to various methods for measuring the amount of an analyte present in a biological fluid using an electrochemical testing process. Various embodiments are disclosed, including the use of AC test signals and the performance of tests having a Total Test Time within about 2.0 seconds or less, and/or having a clinically low Total System Error.
    Type: Grant
    Filed: December 30, 2009
    Date of Patent: April 3, 2012
    Assignee: Roche Diagnostics Operations, Inc.
    Inventors: Eric R. Diebold, Terry A. Beaty, Harvey B. Buck, Jr.
  • Patent number: 7867369
    Abstract: A biosensor having multiple electrical functionalities located both within and outside of the measurement zone in which a fluid sample is interrogated. Incredibly small and complex electrical patterns with high quality edges provide electrical functionalities in the biosensor and also provide the electrical wiring for the various other electrical devices provided in the inventive biosensor. In addition to a measurement zone with multiple and various electrical functionalities, biosensors of the present invention may be provided with a user interface zone, a digital device zone and/or a power generation zone. The inventive biosensors offer improved ease of use and performance, and decrease the computational burden and associated cost of the instruments that read the biosensors by adding accurate yet cost-effective functionalities to the biosensors themselves.
    Type: Grant
    Filed: June 18, 2004
    Date of Patent: January 11, 2011
    Assignee: Roche Diagnostics Operations, Inc.
    Inventors: Raghbir S. Bhullar, Harvey B. Buck, Jr., Brian S. Hill, Paul Douglas Walling, Terry A. Beaty, David W. Burke, Eric R. Diebold
  • Publication number: 20100170807
    Abstract: The present disclosure relates to various methods for measuring the amount of an analyte present in a biological fluid using an electrochemical testing process. Various embodiments are disclosed, including the use of AC test signals and the performance of tests having a Total Test Time within about 2.0 seconds or less, and/or having a clinically low Total System Error.
    Type: Application
    Filed: December 30, 2009
    Publication date: July 8, 2010
    Inventors: Eric R. Diebold, Terry A. Beaty, Harvey B. Buck, JR.
  • Publication number: 20090319312
    Abstract: In particular embodiments, the present invention provides a system and method for governance, risk, and compliance management. For example, a method for governance, risk, and compliance management includes providing an interface for defining a control to be used to reach a goal of an organization. The control provides a procedure to be followed by the organization. The method further includes providing the interface for implementing the control in order to reach the goal of the organization. The method further includes receiving metric data from an external source. The metric data includes a document link. The method further includes providing the interface for accessing, using the document link, one or more documents corresponding to the control. The one or more documents are accessed in such a way as to prevent the one or more documents from losing their status as original.
    Type: Application
    Filed: December 18, 2008
    Publication date: December 24, 2009
    Applicant: Computer Associates Think, Inc.
    Inventors: Mark L. Moerdler, Christopher S. Boswell, Galina Datskovsky, Murali Swaminathan, Bryan R. Diebold, Ying Ding, John D. Benton
  • Publication number: 20090265199
    Abstract: In particular embodiments, the present invention provides a system and method for governance, risk, and compliance management. For example, a method for governance, risk, and compliance management includes providing an interface for defining a control to be used to reach a goal of an organization. The control provides a procedure to be followed by the organization. The method further includes providing the interface for defining a metric for tracking a progress of the organization towards reaching the goal using the procedure. The method further includes receiving metric data from an external source. The metric data corresponds to the metric. The method further includes tracking the progress of the organization towards reaching the goal using at least the metric and the metric data. The method further includes displaying the progress of the organization towards reaching the goal.
    Type: Application
    Filed: December 18, 2008
    Publication date: October 22, 2009
    Applicant: Computer Associates Think, Inc.
    Inventors: Mark L. Moerdler, Christopher S. Boswell, Galina Datskovsky, Murali Swaminathan, Bryan R. Diebold, Ying Ding, John D. Benton, Thomas J. McHale, Michael W. Stricklen
  • Publication number: 20090056120
    Abstract: An electrochemical biosensor with electrode elements that possess smooth, high-quality edges. These smooth edges define gaps between electrodes, electrode traces and contact pads. Due to the remarkable edge smoothness achieved with the present invention, the gaps can be quite small, which provides marked advantages in terms of test accuracy, speed and the number of different functionalities that can be packed into a single biosensor. Further, the present invention provides a novel biosensor production method in which entire electrode patterns for the inventive biosensors can be formed all at one, in nanoseconds—without regard to the complexity of the electrode patterns or the amount of conductive material that must be ablated to form them.
    Type: Application
    Filed: September 25, 2008
    Publication date: March 5, 2009
    Inventors: Raghbir S. Bhullar, Eric R. Diebold, Brian S. Hill, Nigel Surridge, Paul Douglas Walling
  • Publication number: 20090020502
    Abstract: An electrochemical biosensor with electrode elements that possess smooth, high-quality edges. These smooth edges define gaps between electrodes, electrode traces and contact pads. Due to the remarkable edge smoothness achieved with the present invention, the gaps can be quite small, which provides marked advantages in terms of test accuracy, speed and the number of different functionalities that can be packed into a single biosensor. Further, the present invention provides a novel biosensor production method in which entire electrode patterns for the inventive biosensors can be formed all at one, in nanoseconds—without regard to the complexity of the electrode patterns or the amount of conductive material that must be ablated to form them.
    Type: Application
    Filed: September 25, 2008
    Publication date: January 22, 2009
    Inventors: Raghbir S. Bhullar, Eric R. Diebold, Brian S. Hill, Nigel Surridge, Paul Douglas Walling
  • Patent number: 7386937
    Abstract: A method of making a biosensor is provided. The method includes providing an electrically conductive material on a base and partially removing the conductive material using laser ablation from the base so that less than 90% of the conductive material remains on the base and at least one electrode pattern is formed from the conductive material. The at least one electrode pattern has an edge extending between two points. A standard deviation of the edge from a line extending between two points is less than about 6 ?m along the length of the edge.
    Type: Grant
    Filed: May 1, 2006
    Date of Patent: June 17, 2008
    Assignee: Roche Diagnostics Operations, Inc.
    Inventors: Raghbir S. Bhullar, Eric R. Diebold, Brian S. Hill, Nigel A. Surridge, Douglas P. Walling
  • Publication number: 20070197386
    Abstract: An improved selective herbicide, as well of methods of controlling unwanted plants using such a herbicide, are provided. A method for treating undesired vegetation can include providing a selective herbicidal composition that includes a water-soluble selective auxin-type herbicide and a chelating agent complexed with at least one transition metal, and contacting vegetation with a herbicidally effective amount of the composition such that unwanted vegetation is controlled, while desired vegetation is unaffected.
    Type: Application
    Filed: March 14, 2007
    Publication date: August 23, 2007
    Applicant: W. NEUDORFF GMBH KG
    Inventors: R. Diebold, Kim Morgan, Cameron Wilson
  • Patent number: 7073246
    Abstract: A method of making a biosensor is provided. The biosensor includes an electrically conductive material on a base and electrode patterns formed on the base, the patterns having different feature sizes. The conductive material is partially removed from the base using broad field laser ablation so that less than 90% of the conductive material remains on the base and that the electrode pattern has an edge extending between two points. A standard deviation of the edge from a line extending between two points is less than about 6 ?m.
    Type: Grant
    Filed: June 20, 2003
    Date of Patent: July 11, 2006
    Assignee: Roche Diagnostics Operations, Inc.
    Inventors: Raghbir S. Bhullar, Eric R. Diebold, Brian S. Hill, Nigel A. Surridge, Douglas P. Walling
  • Patent number: 7045310
    Abstract: Novel bipyridyl-osmium complex conjugates and their use in electrochemical assays are described. The redox reversible-osmium complexes can be prepared to exhibit unique reversible redox potentials and can thus be used in combination with other electroactive redox reversible species having redox potentials differing by at least 50 millivolts in electrochemical assays designed for use of multiple electroactive species in the same cell and in the same sample without interference between the two or more redox coupled conjugate systems.
    Type: Grant
    Filed: November 1, 2001
    Date of Patent: May 16, 2006
    Assignee: Roche Diagnostics Operations, Inc.
    Inventors: Harvey B. Buck, Jr., Zhi David Deng, Eric R. Diebold
  • Publication number: 20040194302
    Abstract: A method of making a biosensor is provided. The biosensor includes an electrically conductive material on a base and electrode patterns formed on the base, the patterns having different feature sizes. The conductive material is partially removed from the base using broad field laser ablation so that less than 90% of the conductive material remains on the base and that the electrode pattern has an edge extending between two points.
    Type: Application
    Filed: June 20, 2003
    Publication date: October 7, 2004
    Inventors: Raghbir S. Bhullar, Eric R. Diebold, Brian S. Hill, Nigel A. Surridge, P. Douglas Walling
  • Patent number: RE40198
    Abstract: A method and device for detection and quantification of biologically significant analytes in a liquid sample is described. The method includes contacting a volume of a liquid sample with predetermined amounts of at least a first and second redox reversible species having redox potentials differing by at least 50 millivolts. At least one of the redox reversible species comprises a liquid sample diffusible conjugate of a ligand analog of an analyte in the liquid sample and a redox reversible label. A predetermined amount of at least one specific binding partner for each analyte to be measured is combined with the sample and current flow is measured at first and second anodic and cathodic potentials and correlated with current flows for known concentrations of the respective diffusible redox reversible species. Diagnostic devices and kits, including such devices and the specified specific binding partner(s) and redox reversible species are also described.
    Type: Grant
    Filed: September 25, 2003
    Date of Patent: April 1, 2008
    Assignee: Roche Diagnostics Operations, Inc.
    Inventors: Harvey B. Buck, Jr., Zhi David Deng, Eric R. Diebold
  • Patent number: RE41309
    Abstract: An electrochemical biosensor test strip with four new features. The test strip includes an indentation for tactile feel as to the location of the strips sample application port. The sample application port leads to a capillary test chamber, which includes a test reagent. The wet reagent includes from about 0.2% by weight to about 2% by weight polyethylene oxide from about 100 kilodaltons to about 900 kilodaltons mean molecular weight, which makes the dried reagent more hydrophilic and sturdier to strip processing steps, such as mechanical punching, and to mechanical manipulation by the test strip user. The roof of the capillary test chamber includes a transparent or translucent window which operates as a “fill to here” line, thereby identifying when enough test sample (a liquid sample, such as blood) has been added to the test chamber to accurately perform a test. The test strip may further include a notch located at the sample application port. The notch reduces a phenomenon called “dose hesitation”.
    Type: Grant
    Filed: April 9, 2003
    Date of Patent: May 4, 2010
    Assignees: Roche Diagnostics Operations, Inc., Roche Operations Ltd.
    Inventors: William F. Crismore, Nigel A. Surridge, Daniel R. McMinn, Richard J. Bodensteiner, Eric R. Diebold, R. Dale Delk, David W. Burke, Jiaxiong Jason Ho, Robert Kitchel Earl, Brian A. Heald
  • Patent number: RE42953
    Abstract: An electrochemical biosensor test strip with four new features. The test strip includes an indentation for tactile feel as to the location of the strips sample application port. The sample application port leads to a capillary test chamber, which includes a test reagent. The wet reagent includes from about 0.2% by weight to about 2% by weight polyethylene oxide from about 100 kilodaltons to about 900 kilodaltons mean molecular weight, which makes the dried reagent more hydrophilic and sturdier to strip processing steps, such as mechanical punching, and to mechanical manipulation by the test strip user. The roof of the capillary test chamber includes a transparent or translucent window which operates as a “fill to here” line, thereby identifying when enough test sample (a liquid sample, such as blood) has been added to the test chamber to accurately perform a test. The test strip may further include a notch located at the sample application port. The notch reduces a phenomenon called “dose hesitation”.
    Type: Grant
    Filed: December 7, 2001
    Date of Patent: November 22, 2011
    Assignees: Roche Diagnostics Operations, Inc., Roche Operations Ltd.
    Inventors: William F. Crismore, Nigel A. Surridge, Richard J. Bodensteiner, Eric R. Diebold, R. Dale Delk, David W. Burke, Jiaxiong Jason Ho